UBS O'Connor’s AEON Biopharma Inc AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74,997
| Closed | -$114K | – | 663 |
|
|
2024
Q1 | $114K | Hold |
74,997
| – | – | ﹤0.01% | 420 |
|
|
2023
Q4 | $6.55K | Sell |
74,997
-33,921
| -31% | -$2.53K | ﹤0.01% | 469 |
|
|
2023
Q3 | $17.4K | Hold |
108,918
| – | – | ﹤0.01% | 513 |
|
|
2023
Q2 | $9.26K | Sell |
108,918
-3,555
| -3% | -$267 | ﹤0.01% | 549 |
|
|
2023
Q1 | $7.38K | Buy |
+112,473
| New | +$6.49K | ﹤0.01% | 604 |
|
|
2022
Q4 | – | Sell |
-112,473
| Closed | -$8K | – | 484 |
|
|
2022
Q3 | $8K | Sell |
112,473
-11,307
| -9% | -$1.03K | ﹤0.01% | 918 |
|
|
2022
Q2 | $19K | Buy |
+123,780
| New | +$26K | ﹤0.01% | 912 |
|
|
2022
Q1 | – | Sell |
-171,253
| Closed | -$87K | – | 342 |
|
|
2021
Q4 | $87K | Buy |
171,253
+4,593
| +3% | +$2.54K | ﹤0.01% | 859 |
|
|
2021
Q3 | $95K | Hold |
166,660
| – | – | ﹤0.01% | 830 |
|
|
2021
Q2 | $171K | Buy |
+166,660
| New | +$126K | ﹤0.01% | 754 |
|
UBS O'Connor's AEON.WS Position: Q2 2024 in Review
UBS O'Connor sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 74,997 shares — an estimated $114K sold.
UBS O'Connor first reported a position in AEON.WS in Q2 2021 and held it in 10 quarters. The position peaked at $171K in Q2 2021. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.
- UBS O'Connor reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
- UBS O'Connor sold 74,997 AEON Biopharma Inc shares in Q2 2024, an estimated $114K.
- UBS O'Connor first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 10 quarters.
- UBS O'Connor's AEON Biopharma Inc position peaked at $171K in Q2 2021.
- 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.
Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.